Last updated: 31 March 2022 at 5:40pm EST

Advisors Llc Orbi Med Capit... Net Worth




The estimated Net Worth of Advisors Llc Orbi Med Capit... is at least $11 millió dollars as of 25 September 2020. Advisors Capit owns over 950,000 units of Pmv Pharmaceuticals Inc stock worth over $717,250 and over the last 4 years Advisors sold PMVP stock worth over $10,263,435.

Advisors Capit PMVP stock SEC Form 4 insiders trading

Advisors has made over 2 trades of the Pmv Pharmaceuticals Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently Advisors sold 474,500 units of PMVP stock worth $10,263,435 on 29 March 2022.

The largest trade Advisors's ever made was buying 950,000 units of Pmv Pharmaceuticals Inc stock on 25 September 2020 worth over $17,100,000. On average, Advisors trades about 712,250 units every 275 days since 2020. As of 25 September 2020 Advisors still owns at least 475,000 units of Pmv Pharmaceuticals Inc stock.

You can see the complete history of Advisors Capit stock trades at the bottom of the page.



Insiders trading at Pmv Pharmaceuticals Inc

Over the last 4 years, insiders at Pmv Pharmaceuticals Inc have traded over $56,359,813 worth of Pmv Pharmaceuticals Inc stock and bought 3,910,000 units worth $70,380,000 . The most active insiders traders include Peter A. Thompson, Capital Management, L.P.Kol... és Thilo Schroeder. On average, Pmv Pharmaceuticals Inc executives and independent directors trade stock every 16 days with the average trade being worth of $130,810. The most recent stock trade was executed by Advisors Llc Orbi Med Capit... on 22 November 2023, trading 87,786 units of PMVP stock currently worth $195,763.



What does Pmv Pharmaceuticals Inc do?

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing mutant p53 programs, including Wild-type p53 Induced-Phosphatase, R282W, and R273H, as well as other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey.



What does Pmv Pharmaceuticals Inc's logo look like?

Pmv Pharmaceuticals Inc logo

Complete history of Advisors Capit stock trades at Pmv Pharmaceuticals Inc

Dátum
#
Cég
Az érdekelt
Trans.
Tranzakció
Részvények száma Ár per részvény Teljes ár Részvények szíma után Forrás
29 Mar 2022 Advisors Llc Orbi Med Capit...
Eladás 474,500 $21.63 $10,263,435
29 Mar 2022
0
25 Sep 2020 Advisors Llc Orbi Med Capit...
Megvenni 950,000 $18.00 $17,100,000
25 Sep 2020
475,000


Pmv Pharmaceuticals Inc executives and stock owners

Pmv Pharmaceuticals Inc executives and other stock owners filed with the SEC include: